Form 4 for AVXL ANAVEX LIFE SCIENCES CORP.
Accepted 2021-07-01 00:00:00 ET · period of report 2021-06-29 · accession 0001731122-21-001127 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-01 | 2021-06-29 | AVXL | MISSLING CHRISTOPHER U | Pres, CEO, Dir | S - Sale+OE | $26.00 | -51.6K | 1.02M | -5% | -$1.34M |
| D | 2021-07-01 | 2021-06-29 | AVXL | MISSLING CHRISTOPHER U | Pres, CEO, Dir | M - OptEx | $1.32 | +51.6K | 1.07M | +5% | +$68.1K |
| D | 2021-07-01 | 2021-06-29 | AVXL | MISSLING CHRISTOPHER U | Pres, CEO, Dir | M - OptEx | $0.00 | -51.6K | 73.4K | -41% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-06-29 | S | D | 51,620 | $26.00 | 1,018,210 | D | — | — | |
| 2 | Common | Common Stock | 2021-06-29 | M | A | 51,620 | $1.32 | 1,069,830 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-06-29 | M | D | 51,620 | $0.00 | 73,380 | D | $1.32 · — to 2024-05-08 | 51,620 Common Stock | (F1) The options subject to this grant vested over 4 years on May 8, 2015, May 8, 2016, May 8, 2017, May 8, 2018. |